AtriCure, Inc. (ATRC): who owns it and who trades it
As of Nov 16, 2026, ATRC insiders reported 19 open-market sales worth $5.1M and no purchases in the last 12 months, with 28% of the sale value made under pre-set 10b5-1 plans. The largest seller was Salvatore Privitera (Chief Technical Officer), with $1.4M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling AtriCure
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds mostly bought. Famous investors and Congress were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns ATRC
253 funds and institutions reported ATRC shares worth $1.6B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 8.8%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 4.47M | 8.84% | $125M | +11% |
| Wellington Management Group LLP | 3.50M | 6.90% | $97.8M | +3% |
| Vanguard Portfolio Management LLC | 3.13M | 6.18% | $87.5M | +16% |
| Hood River Capital Management LLC | 2.91M | 5.74% | $81.3M | -7% |
| Alliancebernstein L.P. | 2.77M | 5.47% | $79M | -15% |
| Vanguard Capital Management LLC | 2.19M | 4.33% | $61.3M | +2% |
| Nomura Asset Management International Inc. | 1.73M | 3.42% | $48.5M | -4% |
| California State Teachers Retirement System | 1.63M | 3.23% | $58.4M | +2627% |
| Goldman Sachs Group Inc | 1.60M | 3.16% | $44.7M | -4% |
| State Street Corp | 1.39M | 2.74% | $38.9M | +7% |
| Marshall Wace, LLP | 1.33M | 2.63% | $37.3M | -9% |
| Geode Capital Management, LLC | 1.32M | 2.61% | $36.9M | +8% |
| Arrowstreet Capital, Limited Partnership | 1.30M | 2.56% | $36.3M | +367% |
| Dimensional Fund Advisors LP | 1.04M | 2.06% | $29.2M | +5% |
| GW&K Investment Management, LLC | 949,516 | 1.87% | $26.6M | -1% |
| Neuberger Berman Group LLC | 947,982 | 1.87% | $26.6M | -10% |
| Champlain Investment Partners, LLC | 938,567 | 1.85% | $26.3M | -3% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 897,419 | 1.77% | $25.1M | -15% |
| Bank of America Corp | 874,370 | 1.73% | $24.5M | +14% |
| Kennedy Capital Management LLC | 857,787 | 1.69% | $24M | +3% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, ATRC insiders reported $0 of open-market purchases and $5.1M of sales. 28% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | B Kristine Johnson | Director | Sale | 2,452 | $58.48 | $143K | Form 4 |
| Nov 4, 2026 | Salvatore Privitera | Chief Technical Officer | Sale plan | 8,404 | $65.00 | $546K | Form 4 |
| Sep 23, 2026 | Salvatore Privitera | Chief Technical Officer | Sale plan | 4,519 | $60.00 | $271K | Form 4 |
| Sep 11, 2026 | Regina E Groves | Director | Sale | 5,313 | $54.22 | $288K | Form 4 |
| Sep 8, 2026 | Salvatore Privitera | Chief Technical Officer | Sale plan | 3,657 | $55.00 | $201K | Form 4 |
| Sep 2, 2026 | Salvatore Privitera | Chief Technical Officer | Sale plan | 7,763 | $52.50 | $408K | Form 4 |
| Aug 24, 2026 | Karl S. Dahlquist | Chief Legal Officer | Sale | 9,370 | $48.89 | $458K | Form 4 |
| Aug 5, 2026 | Karen Prange | Director | Sale | 3,564 | $38.80 | $138K | Form 4 |
| Aug 5, 2026 | Maggie Yuen | Director | Sale | 3,500 | $38.42 | $134K | Form 4 |
| Jul 29, 2026 | Justin J Noznesky | Chief Mktg & Strategy Of | Sale | 6,182 | $38.80 | $240K | Form 4 |
| Jul 28, 2026 | Vinayak Doraiswamy | Chief Scientific Officer | Sale | 6,000 | $38.88 | $233K | Form 4 |
| Jul 28, 2026 | Sven Wehrwein | Director | Sale | 25,000 | $37.84 | $946K | Form 4 |
| May 20, 2026 | Karen Prange | Director | Sale | 3,000 | $28.65 | $86K | Form 4 |
| May 15, 2026 | Vinayak Doraiswamy | Chief Scientific Officer | Sale | 5,000 | $28.13 | $141K | Form 4 |
| Mar 12, 2026 | Vinayak Doraiswamy | Chief Scientific Officer | Sale | 5,000 | $29.83 | $149K | Form 4 |
| Nov 26, 2025 | Justin J Noznesky | Chief Mktg & Strategy Of | Sale | 5,166 | $37.29 | $193K | Form 4 |
| Nov 25, 2025 | Sven Wehrwein | Director | Sale | 4,967 | $38.00 | $189K | Form 4 |
| Nov 24, 2025 | Sven Wehrwein | Director | Sale | 5,033 | $37.32 | $188K | Form 4 |
| Nov 21, 2025 | Maggie Yuen | Director | Sale | 3,000 | $35.72 | $107K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Salvatore Privitera | Chief Technical Officer | – | $1.4M | Nov 4, 2026 |
| Sven Wehrwein | Director | – | $1.3M | Jul 28, 2026 |
| Vinayak Doraiswamy | Chief Scientific Officer | – | $523K | Jul 28, 2026 |
| Karl S. Dahlquist | Chief Legal Officer | – | $458K | Aug 24, 2026 |
| Justin J Noznesky | Chief Mktg & Strategy Officer | – | $433K | Jul 29, 2026 |
| Regina E Groves | Director | – | $288K | Sep 11, 2026 |
| Maggie Yuen | Director | – | $242K | Aug 5, 2026 |
| Karen Prange | Director | – | $224K | Aug 5, 2026 |
| B Kristine Johnson | Director | – | $143K | Nov 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ATRC short interest
Moderate short interest. 9.6% of ATRC shares are sold short: about 1 share in 10. Over the last 12 reports the number of shares short went up 10%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.89M ATRC shares were sold short, 9.6% of the shares outstanding, up 0.1% from the report before. At the average daily volume of 643,486 shares, buying them all back would take about 7.6 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.89M | 9.61% | +0% | 643,486 | 7.6 |
| Oct 15, 2026 | 4.89M | 9.61% | +1% | 937,500 | 5.2 |
| Sep 30, 2026 | 4.82M | 9.47% | +13% | 1.85M | 2.6 |
| Sep 15, 2026 | 4.28M | 8.41% | +3% | 1.18M | 3.6 |
| Aug 31, 2026 | 4.14M | 8.14% | +6% | 718,483 | 5.8 |
| Aug 14, 2026 | 3.92M | 7.71% | +2% | 642,538 | 6.1 |
| Jul 31, 2026 | 3.86M | 7.60% | -21% | 1.04M | 3.7 |
| Jul 15, 2026 | 4.86M | 9.61% | +9% | 856,705 | 5.7 |
| Jun 30, 2026 | 4.45M | 8.79% | +29% | 1.25M | 3.6 |
| Jun 15, 2026 | 3.44M | 6.80% | +1% | 706,658 | 4.9 |
| May 29, 2026 | 3.40M | 6.72% | -23% | 844,268 | 4.0 |
| May 15, 2026 | 4.43M | 8.75% | +15% | 979,633 | 4.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded ATRC
Since Nov 17, 2024, 1 member of Congress reported 3 purchases and 1 sale of ATRC. The latest was a sale by Gilbert Ray Cisneros, Jr. on Sep 29, 2026, reported Oct 12, 2026.
Purchases 3Sales 1
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Oct 12, 2026 | Report |
| Aug 20, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Sep 10, 2026 | Report |
| Mar 3, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Apr 7, 2026 | Report |
| May 6, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Jun 6, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
AtriCure company events
AtriCure filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 3, 2026.
- Nov 3, 2026ResultsReleased financial results. Filing
- Jul 23, 2026ResultsReleased financial results. Filing
- May 19, 2026LeadershipAt the AtriCure, Inc. 2026 Annual Meeting of Stockholders held on May 18, 2026, the stockholders of the Company approved an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan. Filing
- May 6, 2026ResultsAmended an earlier report. Released financial results. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Feb 17, 2026ResultsReleased financial results. Filing
- Jan 12, 2026AgreementAtriCure, Inc. and its wholly owned subsidiary, AtriCure, LLC (together with the Company, the “ Borrowers ”), entered into a First Amendment to Credit Agreement (as amended, the “ Credit Agreement ”) among the Borrowers, JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
AtriCure financials
Famous investors that hold ATRC
4 of the 50 well-known investors we track reported holding ATRC in their latest 13F filing. The largest position is Ken Griffin's, worth $31.9M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 567,483 | $31.9M | 0.0% | +220% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 321,000 | $18M | 0.0% | +37% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 117,900 | $6.6M | 0.0% | -80% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 42,194 | $2.4M | 0.0% | -45% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named ATRC in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Wellington Management Group LLP | 13G/A | 8.1% |
| Nov 16, 2026 | Wellington Management Group LLP | 13G/A | 8.1% |
| Oct 30, 2026 | Vanguard Portfolio Management | 13G/A | 7.2% |
| Oct 30, 2026 | Vanguard Portfolio Management | 13G/A | 7.2% |
| Oct 5, 2026 | BlackRock, Inc. | 13G/A | 15.4% |
| Oct 5, 2026 | BlackRock, Inc. | 13G/A | 15.4% |
Questions about AtriCure, Inc. (ATRC) stock
Who owns the most ATRC stock?
The largest reported owner of AtriCure, Inc. (ATRC) is BlackRock, Inc., with 8.8% of the company. In total, 253 funds and institutions reported holding ATRC at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are ATRC insiders buying or selling?
In the last 12 months, ATRC insiders reported no open-market purchases and 19 sales worth $5.1M. The latest trade was on Nov 6, 2026. See every trade.
What is the short interest in ATRC?
As of Oct 30, 2026, 4.89M ATRC shares were sold short, 9.6% of the shares outstanding, up 0.1% from the report before. At the average daily volume of 643,486 shares, buying them all back would take about 7.6 trading days (days to cover). See the history.
Have members of Congress traded ATRC?
Yes. 1 member of Congress reported 3 purchases and 1 sale of ATRC since Nov 17, 2024. The latest was reported on Oct 12, 2026. See the trades.
Which famous investors hold ATRC?
4 of the 50 well-known investors we track reported ATRC in their latest 13F filing, including Ken Griffin, Jim Simons, Steve Cohen. The largest position is worth $31.9M. See all holders.
Executive pay
AtriCure's chief executive was paid a total of $9.2M for the year ended Dec 31, 2025, down 17% from $11.1M the year before. In the last 12 months, AtriCure's executives and directors bought no stock on the open market and sold $5.1M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.